|
注册号: Registration number: |
ChiCTR2500100088 |
|
最近更新日期: Date of Last Refreshed on: |
2025-04-02 15:06:35 |
|
注册时间: Date of Registration: |
2025-04-02 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
微创注入肺表面活性物质(LISA)和气管插管-肺表面活性物质-拔管(INSURE)在早产儿牛肺表面活性物质治疗中的比较:一项多中心、前瞻性、真实世界、比较效果研究 |
|
Public title: |
Comparison of Minimally Invasive Surfactant Administration (LISA) and Endotracheal Intubation-Surfactant-Extubation (INSURE) in Preterm Infants Receiving Calf Pulmonary Surfactant Therapy: A Multicenter, Prospective, Real-World, Comparative Effectiveness Study |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
微创注入肺表面活性物质(LISA)和气管插管-肺表面活性物质-拔管(INSURE)在早产儿牛肺表面活性物质治疗中的比较:一项多中心、前瞻性、真实世界、比较效果研究 |
|
Scientific title: |
Comparison of Minimally Invasive Surfactant Administration (LISA) and Endotracheal Intubation-Surfactant-Extubation (INSURE) in Preterm Infants Receiving Calf Pulmonary Surfactant Therapy: A Multicenter, Prospective, Real-World, Comparative Effectiveness Study |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
黄小艺 |
研究负责人: |
刘志伟 |
|
Applicant: |
Xiaoyi Huang |
Study leader: |
Zhiwei Liu |
|
申请注册联系人电话: Applicant telephone: |
+86 21 6407 0434 |
研究负责人电话:
Study leader's |
+86 21 6407 0434 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
huangxiaoyi0233@163.com |
研究负责人电子邮件: Study leader's E-mail: |
liuzhiwei@hotmail.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
上海市徐汇区衡山路910号 |
研究负责人通讯地址: |
上海市徐汇区衡山路910号 |
|
Applicant address: |
No. 910, Hengshan Road, Xuhui District, Shanghai |
Study leader's address: |
No. 910, Hengshan Road, Xuhui District, Shanghai |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
中国福利会国际和平妇幼保健院 |
||
|
Applicant's institution: |
International Peace Maternity and Child Health Hospital of China Welfare Institution |
||
|
研究负责人所在单位: |
中国福利会国际和平妇幼保健院 |
||
|
Affiliation of the Leader: |
International Peace Maternity and Child Health Hospital of China Welfare Institution |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
GKLW-A-2025-004-01 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
国际和平妇幼保健院医学科研伦理委员会 |
||
|
Name of the ethic committee: |
Medical Research Ethics Committee of International Peace Maternity and Child Health Hospital of China Welfare Institution |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2025-01-10 00:00:00 | ||
|
伦理委员会联系人: |
许鸿 |
||
|
Contact Name of the ethic committee: |
Hong Xu |
||
|
伦理委员会联系地址: |
上海市徐汇区衡山路910号 |
||
|
Contact Address of the ethic committee: |
No. 910, Hengshan Road, Xuhui District, Shanghai |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 21 6407 0434 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
gfykyll@163.com |
|
研究实施负责(组长)单位: |
中国福利会国际和平妇幼保健院 |
||||||||||||||||||||||
|
Primary sponsor: |
International Peace Maternity & Child Health Hospital of China welfare institute |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
上海市徐汇区衡山路910号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
No. 910, Hengshan Road, Xuhui District, Shanghai |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
中华国际医学交流基金会 |
||||||||||||||||||||||
|
Source(s) of funding: |
China International Medical Foundation |
||||||||||||||||||||||
|
研究疾病: |
早产儿 |
||||||||||||||||||||||
|
Target disease: |
Preterm infants |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
观察性研究 |
||||||||||||||||||||||
|
Study type: |
Observational study |
||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||
|
研究设计: |
队列研究 |
||||||||||||||||||||||
|
Study design: |
Cohort study |
||||||||||||||||||||||
|
研究目的: |
主要目的:评价 LISA vs. INSURE技术给予牛肺表面活性物质在早产儿中的真实世界有效性。 次要目的: 1. 探索LISA vs. INSURE技术给予牛肺表面活性物质治疗有效性的相关影响因素; 2. 评价 LISA vs. INSURE技术给予牛肺表面活性物质治疗在早产儿中的安全性。 |
||||||||||||||||||||||
|
Objectives of Study: |
Primary Objective: To evaluate the real-world effectiveness of administering calf pulmonary surfactant using LISA vs. INSURE techniques in preterm infants. Secondary Objectives: 1. To explore factors influencing the effectiveness of treatment with calf pulmonary surfactant administered via LISA vs. INSURE techniques. 2. To assess the safety of administering calf pulmonary surfactant using LISA vs. INSURE techniques in preterm infants. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
|||||||||||||||||||||||
|
Inclusion criteria |
|||||||||||||||||||||||
|
排除标准: |
1.严重先天性畸形; 2.影响全身血流动力学的严重紫绀型先天性心脏病; 3.先天性遗传性代谢性疾病; 4.胎粪吸入所致呼吸窘迫; 5.严重感染。 |
||||||||||||||||||||||
|
Exclusion criteria: |
1. Severe congenital malformations; 2. Severe cyanotic congenital heart disease affecting systemic hemodynamics; 3. Congenital hereditary metabolic diseases; 4. Respiratory distress caused by meconium aspiration; 5. Severe infection. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2025-04-02 00:00:00至 To 2026-04-06 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2025-04-02 00:00:00 至 To 2026-04-06 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
无 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
None |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
无 |
|
Blinding: |
None |
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
否No |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
无 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
None |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
病例记录表 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
Case Record Form |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
暂未确定/Not yet |